Detalles de la búsqueda
1.
Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics.
Diabetes Obes Metab
; 25(3): 656-663, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36309941
2.
Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety.
Diabetes Obes Metab
; 24(1): 72-81, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34514696
3.
Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting.
Diabetes Obes Metab
; 22(5): 759-766, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31903680
4.
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugs.
Diabetes Obes Metab
; 21(2): 439-443, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30226296
5.
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registry.
Diabetes Obes Metab
; 21(9): 2169-2173, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31069944
6.
Titration of insulin glargine 100 U/mL when added to oral antidiabetic drugs in patients with type 2 diabetes: results of the TOP-1 real-world study.
Acta Diabetol
; 57(1): 89-99, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31342163
7.
HbA1c target achievement in the elderly: results of the Titration and Optimization trial for initiation of insulin glargine 100 U/mL in patients with type 2 diabetes poorly controlled on oral antidiabetic drugs.
BMJ Open Diabetes Res Care
; 7(1): e000668, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31423316
8.
Effectiveness and tolerability of treatment intensification to basal-bolus therapy in patients with type 2 diabetes on previous basal insulin-supported oral therapy with insulin glargine or supplementary insulin therapy with insulin glulisine: the PARTNER observational study.
Vasc Health Risk Manag
; 11: 569-78, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26604774
9.
Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
Vasc Health Risk Manag
; 9: 711-7, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24259985
Resultados
1 -
9
de 9
1
Próxima >
>>